Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,417.401 million compared to CNY 1,009.847 million a year ago. Operating income was CNY 177.611 million compared to CNY 151.640 million a year ago. Net income was CNY 156.960 million compared to CNY 130.654 million a year ago. Basic earnings per share from continuing operations was CNY 0.17 compared to CNY 0.14 a year ago.